September 2nd, 2013
Losartan Reduces Aortic Enlargement in Marfan Syndrome
Larry Husten, PHD
The COMPARE study provides the first confirmation that the angiotensin receptor blocker losartan reduces aortic enlargement in Marfan syndrome.
September 2nd, 2013
What You See Is Not Always What You Get
Paddy Barrett, MB BCh BAO MRCPI MCTI
The COMPARE trial results prompt Paddy Barrett to wonder: Should disease criteria in clinical trials rely more on molecular than on clinical features?
NEJM Journal Watch — Recent Cardiology Articles- Persistent Symptoms After Valve Replacement for Severe Aortic Stenosis
- Is Diltiazem Safe in Patients with AF Taking Apixaban or Rivaroxaban?
- Does Lowering High Childhood Lipid Levels Prevent Adverse Cardiovascular Events in Adulthood?
- Self-Expanding Supraannular Valve vs. Balloon-Expandable Valve in TAVR for Small Aortic Annulus
- A New TAVR Prosthesis for Aortic Regurgitation Shows Promise